[ Price : $8.95]
FDA approves an Eli Lilly NDA for Portrazza (necitumumab) and its use in combination with two forms of chemotherapy to treat patie...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites A-1 Engineering, Advanced Physician Solutions, Inc., d/b/a Advanced Compounding ...[ Price : $8.95]
Federal Register Final rule: FDA approves an AquaBounty Technologies NADA for use of a rDNA gene construct in genetically engineer...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance: Nonprescription Sunscreen Drug Products Content and Format of Data Submissions ...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance: Over-the-Counter Sunscreens: Safety and Effectiveness Data.[ Price : $8.95]
Federal Register Final order: FDA classifies the prostate lesion documentation system into Class 2.[ Price : $8.95]
Amag Pharmaceuticals responds to an FDA complete response letter on its submission seeking approval for a new single-dose, preserv...[ Price : $8.95]
Angiodroid America withdraws a 510(k) submission for the Angiodroid CO2 Injector for Angiography because CO2 gas itself has not be...